PN
Last reporting period 30 Sep, 2023
Updated —
Last price
—
Market cap $B
1.332
Exchange
XNAS - Nasdaq
-0.035 B
Last period FCFE ,USD
-979%
FCFE has decreased in 3 years
What is FCFE ?
Free cash flow is the amount of cash a company has after all operating expenses, interest and taxes, and capital expenditures have been paid.
See also POINT Biopharma
Company Analysis
PNT valuation, rating, competitors, insights and company profile
Eyestock Rating
PNT financial analysis by Eyestock methodology
Valuation
PNT valuation using historical relative method
Statements
PNT Income Statements, Balance Sheet and Cash Flow Statements
Dividends
PNT dividend yield and annual dividend
Free cash flow is the amount of cash a company has after all operating expenses, interest and taxes, and capital expenditures have been paid.
POINT Biopharma`s FCFE for the period ended 2023-09-30 is -0.035 B USD
